Los Angeles Capital Management LLC Rigel Pharmaceuticals Inc Transaction History

Los Angeles Capital Management LLC

$24.7 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 05, 2024	BUY	$1.12 - $1.57 $222,557 - $311,977	198,712 Added 49.14%	603,123 $892,000
Q3 2023 Nov 06, 2023	BUY	$1.07 - $1.39 $1,011 - $1,313	945 Added 0.23%	404,411 $436,000
Q2 2023 Aug 03, 2023	BUY	$1.12 - $1.82 $16,054 - $26,087	14,334 Added 3.68%	403,466 $520,000
Q1 2023 May 04, 2023	SELL	$1.25 - $2.0 $15,571 - $24,914	-12,457 Reduced 3.1%	389,132 $513,000
Q4 2022 Feb 06, 2023	BUY	$0.67 - $11.9 $79,964 - $1.42 Million	119,350 Added 42.29%	401,589 $602,000
Q3 2022 Nov 02, 2022	BUY	$1.1 - $12.2 $41,591 - $461,282	37,810 Added 15.47%	282,239 $333,000
Q2 2022 Aug 05, 2022	SELL	$0.67 - $3.19 $4,757 - $22,649	-7,100 Reduced 2.82%	244,429 $276,000
Q3 2021 Nov 08, 2021	SELL	$3.5 - $4.5 $82,530 - $106,110	-23,580 Reduced 8.57%	251,529 $913,000
Q2 2021 Aug 05, 2021	SELL	$3.09 - $4.54 $38,285 - $56,250	-12,390 Reduced 4.31%	275,109 $1.19 Million
Q1 2021 May 05, 2021	SELL	$3.35 - $4.93 $1.81 Million - $2.66 Million	-539,922 Reduced 65.25%	287,499 $983,000
Q4 2020 Feb 04, 2021	SELL	$2.35 - $3.74 $267,831 - $426,251	-113,971 Reduced 12.11%	827,421 $2.9 Million
Q3 2020 Nov 02, 2020	BUY	$1.78 - $4.13 $608 - $1,412	342 Added 0.04%	941,392 $2.26 Million
Q2 2020 Aug 05, 2020	BUY	$1.41 - $2.05 $557,466 - $810,500	395,366 Added 72.45%	941,050 $1.72 Million
Q1 2020 May 04, 2020	BUY	$1.27 - $3.0 $367,377 - $867,822	289,274 Added 112.82%	545,684 $851,000
Q4 2019 Feb 07, 2020	BUY	$1.6 - $2.43 $128,824 - $195,651	80,515 Added 45.77%	256,410 $549,000
Q4 2018 Feb 11, 2019	SELL	$2.08 - $3.36 $39,384 - $63,621	-18,935 Reduced 9.72%	175,895 $405,000
Q3 2018 Nov 05, 2018	BUY	$2.6 - $3.59 $184,340 - $254,531	70,900 Added 57.21%	194,830 $625,000
Q2 2018 Jul 31, 2018	BUY	$2.83 - $4.11 $350,721 - $509,352	123,930 New	123,930 $351,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account